Group 1 - OPEC+ has "principally agreed" to increase production in October, marking a strategic shift towards pursuing market share rather than defending prices [1] - The alliance, led by Saudi Arabia and Russia, plans to approve an increase of approximately 137,000 barrels per day, starting to lift previous production cuts [1][3] - The decision aims to restore a previously reduced production of 1.66 million barrels per day, which was initially set to last until the end of 2026 [1][3] Group 2 - Saudi Arabia is pushing for an early execution of the production increase plan to reclaim market share lost to competitors like U.S. shale oil producers [3] - If OPEC+ maintains the monthly increase of about 137,000 barrels, the full withdrawal of the 1.66 million barrels per day cut could occur within a year [3] - Despite a 12% decline in oil prices this year due to increased supply and global trade market turmoil, the market has shown unexpected resilience to OPEC+'s strategic shift [3] Group 3 - The oil options market indicates a strong bearish sentiment, with the trading volume of December 55-dollar put options reaching a new high since early April [5] - The price of December 60-dollar put options surged from $0.59 to $1.35 in three days, reflecting heightened demand for downside risk protection [5] Group 4 - Analysts predict that further production increases will exacerbate the anticipated supply surplus in Q4, putting additional downward pressure on oil prices [6] - Goldman Sachs forecasts that non-OPEC countries (excluding the U.S.) will drive a global market surplus of 1.8 million barrels per day by 2026 [6]

Core Viewpoint - OPEC+ has agreed in principle to gradually increase oil production starting in October, with an expected daily increase of approximately 137,000 barrels, marking a significant shift in its production strategy [1][2]. Policy Shift - The decision to increase production is a continuation and consolidation of OPEC+'s policy shift, moving away from passive production cuts to actively reclaiming market share [1]. - OPEC+ has previously restored 2.2 million barrels per day of suspended production a year earlier than planned, surprising the market [1]. Market Dynamics - Despite warnings of an impending supply surplus, OPEC+ is responding to a relatively tight supply-demand situation during the Northern Hemisphere summer, which has provided room for policy adjustments [2]. - The increase in production is also seen as a response to U.S. President Trump's calls for lower oil prices [2]. Realities and Challenges - The actual implementation of the production increase faces uncertainties, including compliance issues from member countries that have not fully adhered to previous production cuts [4]. - Countries like Angola and Nigeria may struggle to increase production due to insufficient investment and aging infrastructure [4]. - The move to increase production could place additional pressure on OPEC+ members that rely on high oil prices, particularly those unable to boost output, potentially impacting their fiscal revenues [4]. - If OPEC+ maintains the increase of 137,000 barrels per month, it could fully restore the previous daily cut of 1.66 million barrels within a year, but this poses a significant challenge [4].

Summary of BridgeBio Pharma (BBIO) 2025 Conference Call Company Overview - **Company**: BridgeBio Pharma - **Key Products**: Acoramidis, Encaleret - **Focus Areas**: Limb-girdle muscular dystrophy, autosomal dominant hypocalcemia type 1 (ADH1) Key Points Acoramidis Launch and Performance - The launch of acoramidis is described as having a strong start, with increasing momentum in both treatment naive and switch settings [2][3] - Acoramidis is noted for its superior clinical profile, being the only near-complete stabilizer on the market [2] - Key clinical outcomes include: - 50% reduction in hospitalization at 30 months - 40% reduction in all-cause mortality (ACM) and hospitalization at 30 months [3] - Metrics such as gross-to-net revenue have stabilized in the 30% to 40% range, with compliance around 80% [3][5] - New patient additions have accelerated, with 3,751 patients reported by Q2, up from 2,072 in Q1, indicating a growth rate of approximately 90 to 100 patients per week [8][9] Market Dynamics and Competitive Landscape - The discontinuation of Pfizer's Vyndaqel in 2026 is seen as an opportunity for BridgeBio to capture patients who would have been prescribed Vyndaqel, as these physicians are already predisposed to using stabilizers [12] - The polymorph patent covering both Vyndaqel and Vyndamax is expected to protect acoramidis from generic competition, raising the bar for any potential generic manufacturers [13][14] Encaleret Development - Encaleret is being developed for ADH1, with a prevalence rate of about 1 in 25,000, translating to approximately 12,000 individuals in the U.S. [22] - The diagnosis rates for ADH1 are lagging behind prevalence due to the lack of indicated treatments [22][23] - Phase two results showed that 70% of patients normalized both blood and urine calcium levels, which is a significant improvement over conventional therapies [34][35] - The phase three study is designed to evaluate the concurrent normalization of blood and urine calcium over six months, informed by phase two results [35] Limb-Girdle Muscular Dystrophy Insights - Ribitol is crucial for muscle function as it is used by FKRP to glycosylate alpha-dystroglycan, a stabilizing protein in muscle fibers [45] - Phase two results indicated an approximate doubling of glycosylated alpha-dystroglycan levels in patients, with a significant reduction in creatine kinase (CK) levels [52][53] - The study aims for a 5% absolute change in glycosylated alpha-dystroglycan and a 40% reduction in CK for potential accelerated approval [56][57] Competitive Landscape for Hypoparathyroidism - Encaleret is positioned against Yorvipath, with potential advantages such as being an oral medication and offering a urine calcium benefit [43][44] - The treatment goals focus on normalization of blood calcium, urine calcium, and phosphate, rather than complete independence from conventional therapy [41] Future Outlook - The company is optimistic about the continued growth of acoramidis and the potential for encaleret to address unmet needs in hypoparathyroidism and ADH1 [14][44] - Upcoming data presentations and interim analyses are expected to provide further insights into the efficacy and market positioning of both acoramidis and encaleret [56][57] Additional Important Insights - The company emphasizes the importance of genetic testing for undiagnosed patients with ADH1, suggesting that many patients with hypoparathyroidism are not genotyped [28][23] - The phase three trial for encaleret is designed to be powered for success based on the promising phase two results, indicating a strong confidence in the product's potential [35][40]

Report Industry Investment Rating - All the analyzed energy and chemical products are rated as "volatile", including crude oil, fuel oil, asphalt, polyester, rubber, methanol, polyolefins, and polyvinyl chloride [1][2][4][5][6] Core Viewpoints - OPEC+ may consider further increasing oil production in the Sunday meeting, which could put pressure on oil prices if the increase exceeds expectations. The market is also affected by factors such as Russian oil exports and US inventory data [1] - For fuel oil, the reduction of arbitrage cargo inflows from the West and the expected decrease in high - sulfur shipments from Iran and Russia may provide some support, but overall demand lacks significant highlights [2] - In the asphalt market, the increase in demand in the northern regions in September may drive price increases, but the rise may be limited by increased supply in some areas. The supply - demand contradiction is expected to ease [2] - Polyester products are affected by factors such as high PX supply, increased TA maintenance, and under - expected seasonal improvement in terminal demand, with prices expected to follow the cost - side fluctuations [4] - The rubber market is supported by factors such as inventory reduction and favorable heavy - truck sales data, but is also affected by产区 weather and demand conditions, with prices expected to be volatile [4] - Methanol prices are expected to enter a phased bottom area in September due to limited supply growth and expected demand recovery [5] - Polyolefins are expected to maintain narrow - range fluctuations in September as the supply and demand are both strong and the cost - side is stable [5] - PVC prices are expected to be volatile and weak in September due to weak real - estate construction demand and expected export decline, but there is a risk of policy - driven speculation [6] Summary by Directory Research Views - **Crude Oil**: On Wednesday, oil prices dropped significantly. WTI October contract closed at $63.97/barrel, down $1.62 or - 2.47%. Brent November contract closed at $67.60/barrel, down $1.54 or - 2.23%. SC2510 closed at 483.6 yuan/barrel, down 8.2 yuan or - 1.67%. OPEC+ may consider further increasing production. Russian oil exports in August slightly increased, and US inventory data showed a rise in crude and distillate stocks and a decline in gasoline stocks. The market is waiting for the OPEC+ production decision, and an unexpected increase in production could pressure oil prices [1] - **Fuel Oil**: On Wednesday, FU2510 closed down 0.04% at 2840 yuan/ton, and LU2511 closed down 0.85% at 3512 yuan/ton. The reduction of Western arbitrage cargo inflows and the expected decrease in high - sulfur shipments from Iran and Russia may support the market, but overall demand lacks highlights. US sanctions on Iranian trade may affect high - sulfur fuel oil delivery [2] - **Asphalt**: On Wednesday, BU2510 closed down 0.36% at 3550 yuan/ton. This week, the social inventory rate was 32.97%, down 0.46% week - on - week; the refinery inventory was 26.24%, down 0.50% week - on - week; and the refinery operating rate was 33.53%, down 2.90% week - on - week. The increase in demand in the northern regions in September may drive price increases, but supply increases in some areas may limit the rise [2] - **Polyester**: TA601 closed at 4732 yuan/ton, down 0.5%; EG2601 closed at 4331 yuan/ton, down 0.18%. PX supply is high, TA maintenance is increasing, and terminal demand improvement is under - expected. The prices of polyester products are expected to follow the cost - side fluctuations [4] - **Rubber**: On Wednesday, RU2601 rose 15 yuan/ton to 15885 yuan/ton, NR rose 5 yuan/ton to 12715 yuan/ton, and BR rose 65 yuan/ton to 11885 yuan/ton. As of August 31, 2025, China's natural rubber social inventory decreased. The market is affected by factors such as weather, demand, and inventory, with prices expected to be volatile [4] - **Methanol**: The prices of methanol and its downstream products are given. Due to profit recovery, MTO device may resume production, and demand is expected to recover in September. Supply growth is limited, and prices are expected to enter a phased bottom area [5] - **Polyolefins**: The prices and profit margins of polyolefins are provided. In September, supply and demand are both strong, and inventory is transferring from society to downstream. Prices are expected to maintain narrow - range fluctuations [5] - **Polyvinyl Chloride**: The prices in different regions are presented. The real - estate construction recovery is weak, and exports are expected to decline due to anti - dumping duties. Prices are expected to be volatile and weak in September [6] Daily Data Monitoring - The table provides data on the basis of various energy and chemical products, including spot prices, futures prices, basis, basis rates, price changes, and the quantile of the latest basis rate in historical data [7] Market News - OPEC+ may consider further increasing oil production in the Sunday meeting to regain market share. An additional increase would mean starting to lift the second - layer production cuts, about 1.65 million barrels per day, 1.6% of global demand, more than a year ahead of schedule [11] - Russian oil exports by sea slightly increased in August. However, exports to India decreased by 21% month - on - month to 1.3 million barrels per day. The US imposed a 25% punitive tariff on Indian products exported to the US in August [11] Chart Analysis - **Main Contract Prices**: The report presents the closing price charts of main contracts for various energy and chemical products from 2021 to 2025, including crude oil, fuel oil, asphalt, LPG, PTA, ethylene glycol, etc. [13][15][17] - **Main Contract Basis**: The basis charts of main contracts for different products are shown, such as crude oil, fuel oil, low - sulfur fuel oil, asphalt, etc. [25][27][31] - **Inter - period Contract Spreads**: The charts of spreads between different contracts for products like fuel oil, asphalt, PTA, ethylene glycol, etc. are provided [39][41][44] - **Inter - product Spreads**: The charts of spreads and ratios between different products are presented, including crude oil's internal - external spreads, B - W spreads, fuel oil's high - low sulfur spreads, BU/SC ratio, etc. [56][58][62] - **Production Profits**: The production profit charts of products such as ethylene - made ethylene glycol, PP, and LLDPE are shown [64][65][67] Team Introduction - The report introduces the members of the energy and chemical research team, including Zhong Meiyan, the assistant director and energy and chemical director, Du Bingqin, an analyst for crude oil, etc., Di Yilin, a rubber/polyester analyst, and Peng Haibo, a methanol/PE/PP/PVC analyst [70][71][72]

Financial Data and Key Metrics Changes - The company reported organic growth of 2% in Q3, which was below the expected 5% and the street's expectations [4][26] - MyDay product line experienced double-digit growth, with MyDay multifocal growing by 20% [7] - The company anticipates a similar performance in Q4 as in Q3, with expectations of improved inventory levels and revenue from private label products [13][54] Business Line Data and Key Metrics Changes - MyDay's growth was attributed to successful fitting sets and trial lenses provided to optometrists, leading to increased sales [6][7] - Clarity, the private label product, faced inventory drawdowns as retailers anticipated new private label contracts, impacting sales negatively in Q3 [9][10] - The company expects to replenish private label inventory in Q4, which should help stabilize sales [11][13] Market Data and Key Metrics Changes - The e-commerce channel in China saw a significant reduction in inventory, dropping from six months to two months, impacting sales negatively [15][16] - Pricing in the U.S. remains stable, while competitive pricing pressures are noted in Asia Pacific, particularly in e-commerce channels [21][22] - The overall market growth is projected to be 4% to 6%, with the company expecting to maintain or regain market share as MyDay capacity improves [50][53] Company Strategy and Development Direction - The company is focusing on increasing MyDay production capacity to meet demand and improve market share in the daily silicone hydrogel segment [54][45] - There is an ongoing effort to enhance operational efficiency and leverage revenue growth, particularly in the CooperSurgical business [71][72] - The management is open to considering a separation of CooperVision and CooperSurgical if market valuations do not improve, but currently believes in the synergy of keeping both together [66][67] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying market dynamics, expecting a return to mid-single-digit growth in the contact lens market [66][59] - The company acknowledges recent challenges in organic growth but believes that improvements in MyDay supply will lead to better performance in the future [85] - Management noted that consumer purchasing behavior remains stable, with continued demand for premium products [30][31] Other Important Information - The company is experiencing pricing pressures in certain markets but maintains a positive pricing environment overall [21][22] - Free cash flow is expected to improve as capital expenditures decrease and operational cash flow increases [79][80] - The company plans to utilize free cash flow for debt reduction and stock buybacks, indicating a more aggressive approach to returning value to shareholders [82] Q&A Session Summary Question: What were the issues affecting Q3 earnings? - Management explained that the organic growth was impacted by inventory drawdowns in Clarity due to private label contracts and reduced e-commerce sales in China [4][10][15] Question: How is the company addressing pricing competition? - Management noted that while there is aggressive pricing in Asia Pacific, they have chosen not to engage in price wars, focusing instead on maintaining profitability [22][24] Question: What is the outlook for the MyDay product line? - Management confirmed that MyDay is expected to see significant growth as production capacity increases, with double-digit growth already observed in Q3 [54][45] Question: What is the company's strategy regarding potential separation of business units? - Management stated that they would consider separating CooperVision and CooperSurgical if market valuations do not improve, but currently see value in keeping them together [66][67] Question: How does the company plan to improve free cash flow? - Management indicated that free cash flow is expected to improve as capital expenditures decrease and operational efficiencies are realized [79][80]

Core Viewpoint - The company demonstrated robust operational capabilities with double-digit growth in revenue and performance despite intensified industry competition and diminishing effects of national subsidies [1][2]. Financial Performance - In H1 2025, the company achieved operating revenue of 252.33 billion yuan, a year-on-year increase of 15.68%, and a net profit attributable to shareholders of 26.01 billion yuan, up 25.04% year-on-year [2]. - In Q2 2025, the company reported operating revenue of 123.90 billion yuan, reflecting a year-on-year growth of 10.99%, and a net profit of 13.59 billion yuan, which is a 15.14% increase year-on-year [2]. Business Segments - The C-end domestic sales share showed a strong recovery, with the smart home business growing by 13% year-on-year in H1 2025. The company’s brands gained market share in domestic air conditioning, refrigeration, and washing machine markets by 3.7, 1.7, and 2.8 percentage points respectively [2]. - The B-end business also continued to improve, with an overall year-on-year growth of 21% in H1 2025, particularly in industrial technology, building intelligence, and robotics sectors, which grew by 29%, 24%, and 8% respectively [2]. Profitability Metrics - In Q2 2025, the company's gross margin was 26.17%, a decrease of 0.4 percentage points year-on-year, while the net profit margin improved to 11.22%, an increase of 0.38 percentage points year-on-year [3]. - The company experienced a positive contribution from financial expenses, amounting to 3.15 billion yuan, which is an increase of 1.98 billion yuan year-on-year, benefiting from improved foreign exchange gains due to the appreciation of the euro against the yuan [3]. Investment Outlook - The company maintains its profit forecast for 2025-2027, with expected EPS of 5.70, 6.30, and 6.82 yuan respectively, reflecting year-on-year growth of 14%, 11%, and 8% [1]. - The target price is set at 87.15 yuan, corresponding to a 15X valuation for 2025, with a maintained "buy" rating [1].

Core Insights - Semiconductor companies, including SMIC and Zhongwei, reported strong revenue growth in their recent financial results, indicating a robust demand in the semiconductor industry [4][5]. - Gree Electric Appliances demonstrated resilience with stable net profits despite a slight decline in overall revenue, focusing on innovation and diversification of its product offerings [11][12]. - Yingstone Innovation achieved significant revenue growth driven by market expansion and new product launches, while also increasing its R&D investments to enhance competitiveness [18][19]. Semiconductor Industry - SMIC reported a revenue of 32.348 billion yuan for the first half of 2025, a year-on-year increase of 23.1%, with a net profit of 2.301 billion yuan, up 39.8% [4]. - Zhongwei's revenue reached 4.961 billion yuan, reflecting a growth of approximately 43.88%, with a net profit of 706 million yuan, up 36.62% [4][5]. - Zhongwei's wafer foundry business revenue was 30.353 billion yuan, a 25.9% increase year-on-year, driven by higher sales volume and average selling prices [4][5]. - Yingstone's semiconductor revenue grew by 27.17%, with a significant increase in orders, indicating a transition from a technology breakthrough phase to a volume production phase [9][10]. Gree Electric Appliances - Gree's revenue for the first half of 2025 was 97.325 billion yuan, a decrease of 2.46%, while net profit was 14.412 billion yuan, an increase of 1.95% [11][12]. - The company aims to reduce reliance on its air conditioning business, with consumer appliances accounting for 78.03% of revenue, down 5.09% year-on-year, while industrial products and green energy saw over 15% growth [13][14]. - Gree's R&D investment reached 3.892 billion yuan, a 7.05% increase, reinforcing its technological edge in the industry [15][16]. Yingstone Innovation - Yingstone reported a revenue of 3.671 billion yuan, a 51.17% increase, with a net profit of 520 million yuan, up 0.25% [18]. - The company significantly increased its R&D spending to 561 million yuan, doubling year-on-year, which accounted for 15.30% of its revenue [19]. - Yingstone plans to expand its product offerings into the drone market, leveraging its strengths in panoramic imaging technology [21].

Core Viewpoint - Bank of America Securities has downgraded the earnings per share forecast for Shenzhou International (02313) by 2% and 3% for the next two years, while also lowering the target price from HKD 73 to HKD 71.8, despite maintaining a "Buy" rating due to strong sales growth from major clients [1] Group 1: Financial Performance - Shenzhou International's gross margin performance in the first half of the year was below expectations, with a reported gross margin of 27.1% [1] - The company experienced strong revenue performance, partly due to favorable order timing [1] - The forecast for the second half of the year indicates only a slight improvement in gross margin, remaining below the 28.1% expected for 2024 and the pre-pandemic level of over 30% [1] Group 2: Market Position and Client Performance - Major clients of Shenzhou International showed significant sales growth that outperformed global industry peers in the first half of the year [1] - The recovery of Nike is anticipated to be a key factor influencing Shenzhou's stock performance moving forward [1]

Financial Data and Key Metrics Changes - Consolidated net income increased by 30% to a record $177.3 million or $1.26 per diluted share in 2025, up from $136.6 million or $0.97 per diluted share in 2024 [7][8] - Consolidated operating income and net sales for Q3 2025 increased by 22% and 21% respectively compared to 2024 [8] - Cash flow from operating activities increased by 8% to $231.2 million in 2025, representing 130% of net income [9][10] - Consolidated EBITDA increased by 21% to $316.4 million in 2025, up from $261.4 million in 2024 [10] Business Line Data and Key Metrics Changes - Flight Support Group's net sales increased by 18% to a record $802.7 million in 2025, driven by 13% organic growth and acquisitions [15][17] - Flight Support Group's operating income increased by 29% to a record $198.3 million in 2025 [17][18] - Electronic Technologies Group's net sales increased by 10% to a record $355.9 million in 2025, with 7% organic growth [19][20] - Electronic Technologies Group's operating income increased by 7% to $81 million in 2025 [20][21] Market Data and Key Metrics Changes - The defense business within the Flight Support Group is experiencing significant growth due to increased demand from the U.S. and allies [16][17] - The Electronic Technologies Group's defense organic net sales increased by over 6% in 2025, with a strong order volume and record backlog [20] Company Strategy and Development Direction - The company is focused on growth within commercial aviation, defense, and space markets, supported by a favorable pro-business environment [6][7] - The acquisition strategy remains disciplined, with a focus on identifying businesses that complement existing operations and strengthen strategic positions [24] - The company aims to maximize long-term shareholder value through a balanced approach of strategic acquisitions and strong organic growth initiatives [24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future growth opportunities, citing strong organic demand and a robust acquisition pipeline [23][24] - The company is well-positioned to support defense initiatives, particularly in missile defense, as the U.S. government prioritizes cost efficiency [16][37] - Management noted that while there are pockets of destocking in the market, overall demand remains strong [81][84] Other Important Information - The company paid its 94th consecutive semiannual cash dividend at a rate of $0.12 per share, representing a 9% increase over the prior dividend [11] - The acquisition of Gables Engineering is expected to be accretive to earnings within a year following the acquisition [12][30] Q&A Session Summary Question: How is the Gables acquisition performing relative to expectations? - Management indicated that the acquisition is performing as expected, but it is still early days [30] Question: Is the lower tax rate sustainable? - The CFO noted that the lower rate was primarily a cash benefit and projected an effective annual rate of around 19% to 20% going forward [32] Question: Can you elaborate on missile defense opportunities? - Management highlighted ongoing orders related to missile defense and emphasized the importance of both legacy and new technology defense [36][37] Question: What are the organic growth drivers in the Flight Support Group? - The parts business grew in the low teens, with significant growth in repair and overhaul and specialty products driven by defense business [41][43] Question: What is the outlook for margins in the Flight Support Group? - Management expects margins to be in the 24% range going forward, with the potential for continued improvement [56] Question: How is the company managing supply chain challenges? - Management reported improvements in supply chain issues, with a robust inspection process in place to manage incoming parts [106][108]

Financial Data and Key Metrics Changes - The company reported a net sales increase of 11.5% year over year, reaching ILS 3,100,000,000 for the quarter, with a 15.5% increase when excluding the impact of a stronger shekel [42][43] - EBIT improved significantly, with higher operating profit attributed to increased net sales and ongoing productivity measures, despite raw material price inflation [43][44] - Net income was negatively impacted by increased financing and tax expenses, with financing expenses rising by ILS 57,000,000 in Q2 due to the stronger shekel and higher interest rates [45][46] Business Line Data and Key Metrics Changes - Strauss Israel saw a 9% growth in sales, driven by both volume and price increases, with Health and Wellness performing particularly well [14][48] - The coffee segment in Israel experienced volume increases, especially in roasted and ground coffee, although EBIT remained stable due to rising coffee prices [16][49] - The international coffee business, particularly in Brazil, reported a significant turnaround with a 30% increase in sales, primarily driven by price increases [20][21] Market Data and Key Metrics Changes - The company increased its overall market share in Israel from 34.1% to 35.1%, despite price increases in several segments [18] - The water business experienced 4-5% top-line growth in Q2, supported by a higher installed base and improved sales mix, although impacted by the war in June [50] - In China, the company faced increased competition, particularly from Xiaomi, which affected sales and net income [27][28] Company Strategy and Development Direction - The company is focusing on core activities and major brands to improve profitability and market share, with a strong emphasis on productivity and operational excellence [34][36] - New product launches, including alternative milk and water purification machines, are expected to drive growth in the coming quarters [31][33] - The company aims to transition from a single product to a multiproduct company, enhancing its market position and expanding its product offerings [26][36] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges from inflation and raw material costs but expressed confidence in the company's ability to pass on costs to consumers [63] - The company expects improvements in net income in the coming quarters as one-time financial costs and tax issues are resolved [63] - Future growth is anticipated from productivity initiatives and new product launches, with a focus on maintaining EBIT margins despite rising costs [41][63] Other Important Information - The company received a stable outlook upgrade and maintained a strong AA1 rating, reflecting its solid financial position [47] - The cocoa prices have shown a significant decrease, which is expected to positively impact the funding indulgence segment moving forward [55][56] Q&A Session Summary Question: What are the expected benefits of the new Jotvita facility? - The new facility will address unmet market demand, allowing for a substantial increase in sales volume and value, thereby improving EBIT and margins [51][52] Question: What relief is being seen in commodity pricing? - Some relief is noted in coffee prices, although recent increases are concerning. Cocoa prices have decreased significantly, which is expected to benefit the funding indulgence segment [55][56] Question: How will the acquisition of JDE Peet by Keurig impact the markets? - The company does not anticipate significant impacts in its operating markets, as competition remains strong and JD is already a competitor in those regions [58][59]